The major symptom of spinocerebellar atrophy (SCA) is cerebellar or spinal ataxia. Noradrenergic and serotonergic fibers project to the cerebellum and the spinal cord, and regulate the motor systems. Furthermore, dopamine (DA)-containing immunoreactive fibers and some dopaminergic receptor subtypes have been found in rat cerebellar cortex, 1) and microinjection of dopaminergic agonists and antagonists into the rat cerebellum reportedly decrease locomotor activity. 2, 3) In patients with olivo-ponto-cerebellar atrophy, which is a type of spinocerebellar atrophy, the DA releaser amantadine improves their ataxia.
In patients with olivo-ponto-cerebellar atrophy, which is a type of spinocerebellar atrophy, the DA releaser amantadine improves their ataxia. 4) These lines of evidence suggest that dopaminergic system in the cerebellum is partly involved in motor system regulation.
Rolling mouse Nagoya (RMN) has been extensively studied morphologically and physiologically as an animal model of SCA. This mouse is shown to have the mutation in the gene encoding the P/Q-type voltage-dependent Ca 2ϩ channel a 1A subunit and changes of voltage sensitivity in cerebellar Purkinje cells. 5) And the apoptotic cell death of cerebellar granule cells was increased in RMN, which is considered as an example of delayed cerebellar maturation. 6) Although some reports have indicated that the metabolism of noradrenaline (NA) 7) or serotonin (5-HT) 8) is altered in ataxic mice including RMN, no study has investigated the DA level in their cerebellum, brain stem and spinal cord.
Thyrotropin-releasing hormone (TRH) and its stable analogs produce a number of physiological and behavioral effects in both animals and humans. Several studies have showed that these agents enhance locomotor activity and ameliorate cerebellar ataxia in rats and mice. [9] [10] [11] [12] [13] [14] [15] In addition, these agents exert neuroprotective effects in rodents with spinal cord injury and brain trauma [16] [17] [18] [19] [20] and anticonvulsive effects in amygdaloid-kindled rats. 21) Clinical studies have also shown that TRH, and its synthetic analog taltilerin hydrate, are effective for treatment of hereditary ataxias, including olivo-ponto-cerebellar atrophy and Machado-Joseph disease, which is a type of spinocerebellar atrophy. [22] [23] [24] Taltirelin hydrate and another TRH analog, YM-14673, have been shown to alter the metabolism of acetylcholine 25, 26) and DA, 27) and activate the dopaminergic system. 11, 13, 28) In the present study, we measured the contents and concentrations of DA as well as NA and 5-HT, and the effects of the synthetic TRH analog taltirelin hydrate on these monoamine levels and locomotor activity, in the murine ataxia model RMN.
MATERIALS AND METHODS

Preparation of Ataxic Model Mice
All the experimental protocols were approved by the Animal Care and Use Committee of Nagoya City University and were conducted in accordance with the guidelines of the National Institute of Health and The Japanese Pharmacological Society.
The RMN model was produced at Nagoya City University, but originally obtained from Dr. S. Oda, the Laboratory of Animal Management and Resources, Division of Biosphere Dynamics, Department of Biosphere Resources Science, Nagoya University Graduate School of Bioagricultural Sciences. Mice homozygous for the mutation were obtained by intercrossing heterozygous pairs. The homozygous mutants were easily recognized by their ataxic gait. In this paper, the term RMN refers to the homozygous mutants (rol/rol). To compare the native neurotransmitter levels in RMN, wild type (ϩ/ϩ) and heterozygous (ϩ/rol) mice were regarded as controls, since ences in tyrosine hydroxylase activity between the heterozygous and wild type. 29) Animals were allowed free access to food and water and maintained under a 12 h light/dark cycle in temperature-and humidity-controlled rooms.
Measurement of Motor Activity
The spontaneous motor activity of each mouse was measured for 30 min with an Animex counter (Animex III; Shimadzu, Kyoto, Japan), and the number of falls was counted by behavioral observation at the same time. Fall index was estimated as: fall indexϭnumber of falls/spontaneous motor activityϫ100.
Drug Administration In the experiments to evaluate the effects of taltirelin on the contents of monoamines and fall index of RMN, taltirelin hydrate (1 mg/kg) or vehicle was administered daily for 7 d after the measurement of motor activity in 9-week-old RMN. Taltirelin hydrate (Tanabe Seiyaku Co., Ltd.) was dissolved in 0.9% w/v physiological saline and administered daily intraperitoneally (i.p.) at 0.1 ml/10 g. Control mice received the same volume of vehicle. At 27 h after the last administration, their spontaneous motor activity and number of falls were measured again.
Measurement of NA, DA, and 5-HT Immediately after the measurement of spontaneous motor activity, the mice were killed by inhalation of ether. The cerebellum, brain stem and spinal cord were rapidly removed and kept at Ϫ80°C. The dissected samples were weighed, homogenized in 0.4 ml of 0.2 M perchloric acid including 0.1 mM ethylenediamine-N,N,NЈ,NЈ-tetraacetic acid disodium salt (Na2EDTA) and 0.1 mg/ml 3,4-dihydroxybenzylamine (DHBA) as an internal standard with a Handy Sonic (Tomy Seiko Co., Ltd.), and centrifuged at 10000ϫg for 15 min. The supernatants were collected into microtubes containing 1 M sodium acetate and analyzed by HPLC with electrochemical detection. The mobile phase was composed of 83% phosphate buffer containing 5 mg/l Na2EDTA, 500 mg/l sodium octylsulfate and 17% methanol. The flow rate was maintained at 0.23 ml/min and the samples were injected into the column (2.1fϫ150 mm; EICOMPAK CA-5ODS; Eicom, Kyoto, Japan) in 10-ml aliquots. The substances were oxidized with a graphite electrode at a potential of ϩ450 mV relative to an Ag/AgCl reference electrode, and the electrochemical detector (ECD-300; Eicom) was set at a gain of 0.5 nA full scale. The peaks generated were recorded and their height was measured.
Statistical Analysis All data are expressed as meanϮ S.E.M. To compare the contents and concentrations of monoamines in each tissue, Student's t-test was used. To evaluate the effect of taltirelin on the fall index, paired t-test was used. Differences at pϽ0.05 (two-tailed) were considered to be significant.
RESULTS
Changes in Monoamines in the Central
Nervous System of RMN The body weight of RMN was lower than that of control mice (Table 1) . In homozygous RMN, the weight loss of the cerebellum and spinal cord, but not that of the brain stem, was significant. The contents and concentrations of monoamines in each tissue were then compared between RMN and controls (Table 2) . Since there was no difference in the cerebellar contents of NA, DA and 5-HT between RMN and the control mice, their concentrations were significantly increased in RMN due to the loss of tissue weight; the increase in DA concentration was particularly marked (ϩ41.4%). There was a slight, non-significant difference of brain stem weight between RMN and controls. However, as the NA content of the brain stem in RMN was lower than that of the control, the concentration of NA in this area was not increased in RMN. As the brain stem contents of DA and 5-HT were similar between RMN and the control mice, the concentrations of DA and 5-HT were elevated in RMN, although the elevation of the DA concentration was not significant. In the spinal cord, the NA content was markedly decreased in RMN (Ϫ35.3%), and thus the concentration also tended to be decreased. As the contents of DA and 5-HT did not differ significantly between the groups, the concentrations of these substances were increased in this area in RMN, and the elevation of 5-HT concentration (ϩ30.7%), in particular, was significant.
Amelioration of Motor Disturbance by Taltirelin without Change in Monoamine Contents or Concentrations
Administration of taltirelin hydrate (1 mg/kg/d, 7 d) ameliorated the degree of motor disturbance, as the evidenced by a significant decrease in the fall index of RMN (Fig. 1) , while having no effect on body weight, weight loss of central nervous system regions. At the same time, however, neither contents nor concentrations of NA, DA and 5-HT in RMN were altered by taltirelin administration (Table 3) .
DISCUSSION
Whole body weight, and the weights of the cerebellum, brain stem and spinal cord in RMN, were lower than those of control mice. The most noteworthy finding of the present study was that the contents of all the monoamines measured did not change markedly in cerebellum, while their concentrations were significantly increased. These differences between contents and concentrations are most likely attributable to the degree of weight loss of these tissues. In particular, the increase of DA concentration in cerebellum was marked. This is the first report which measured the DA concentration in the cerebellum of ataxic model mice. Enhancement of NA or 5-HT metabolism in the cerebellum and spinal cord has been demonstrated in mice with cerebellar ataxia, including RMN, and the degree and extent of the increase in NA or 5-HT concentration have been suggested to be well correlated with the degree of cerebellar weight loss. 7, 8) In the present study, the concentration of not only NA and 5-HT but also DA was significantly increased in the RMN cerebellum, suggesting that cerebellar DA metabolism is altered in this model. Barili et al. have shown that the rat cerebellar cortex contains various DA receptor subtypes. 1) In particular, Purkinje neurons, the only efferent neurons of the cerebellum projecting to cerebellar nuclei, exhibit the highest DA receptor protein immunoreactivity in the cerebellum. Furthermore, microinjection of DA receptor antagonists into the cerebellum alters locomotor activity in rats.
3) These reports suggest that DA receptors located in the cerebellum are involved in the modulation of motor output. In RMN, the abnormal expression of tyrosine hydroxylase, which is a ratelimiting enzyme in the synthesis of catecholamines, is found in cerebellar Purkinje cells at 2 weeks-old and this expression increases age-dependently, while there are a few tyrosine hydroxylase-positive cells in wild-type mice cerebellum through the age. 30) Thus, the alterations of monoamine concentration in RMN may reflect the increasing of the tyrosine hydroxylase activity.
Several previous studies have demonstrated that TRH and its analogs taltirelin and YM-14673, can ameliorate the gait of ataxic mutant mice and also rats with 3-acetylpyridine-induced ataxia. 9, 10, 14, 15, 31) We examined whether repeated administration of taltirelin hydrate (1 mg/kg, i.p.) affected the concentrations of NA, DA and 5-HT and the behavior of RMN. Although there was an improvement of motor disturbance, as evidenced by a decrease in the fall index, the monoamine contents and concentrations were unaltered. In normal rats, systemic administration of DA receptor antagonists and lesioning of the unilateral nigrostriatal dopaminergic pathway by 6-hydroxydopamine reportedly reduce the locomotor stimulating action of tartilerin.
11) Furthermore, a microdialysis study has shown that taltirelin increase the extracellular levels of DA and its metabolites, and also NA and 5-HT metabolites, in some brain regions, suggesting that taltirelin enhances DA release and stimulates the monoamine system. 27) In those experiments, taltirelin was administered to normal rats only once, and the effects were observed 30-180 min after administration. Kinoshita et al. showed that the ameliorating effect of repeated taltirelin administration was maintained for 3 weeks after withdrawal of the drug, when the concentration of taltirelin was undetectable, 32) supporting the possibility that the improvement of the fall index observed in the present study was due to a chronic, rather than an acute, effect of taltirelin. Because the metabolism of NA, DA and 5-HT may be changed in ataxic mice, repeated administration of taltirelin may bring about changes in the metabolism of monoamines. Taltirelin and other analogs of TRH have been shown to have a neuroprotective effect in animals with ischemic or traumatic injury of the central nervous system. [16] [17] [18] [19] Such multiple effects of taltirelin in the central nervous system may have contributed to the amelioration of ataxia we observed in the present study.
In conclusion, this is the first report to have demonstrated changes in the level of DA in addition to those of NA and 5-HT, in a murine ataxia model. In the cerebellum of RMN, the concentrations of NA, DA and 5-HT were significantly elevated. In addition, the concentration of 5-HT was significantly increased in the brain stem and spinal cord. Repeated administration of taltirelin ameliorated the ataxia of RMN, while having no effect on body weight, weight loss of central nervous system regions, or monoamine concentrations. 
